Tonix Pharmaceuticals Holding Corp (TNXP)

01:00 AM

Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight - GlobeNewswire Inc.

01:00 AM

Feb 28, 2025

Tonix Pharm stock plunges to 52-week low of $7.84 By Investing.com - Investing.com Australia

Feb 28, 2025

Feb 28, 2025

Tonix Pharm stock plunges to 52-week low of $7.84 - Investing.com

Feb 28, 2025

Feb 27, 2025

Tonix reports positive results in TNX-1500 phase 1 trial - MSN

Feb 27, 2025

Feb 24, 2025

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025 - Smartkarma

Feb 24, 2025

Feb 24, 2025

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025… - Yahoo Finance

Feb 24, 2025

Feb 24, 2025

(TNXP) Investment Analysis - Stock Traders Daily

Feb 24, 2025

Feb 13, 2025

(TNXP) On The My Stocks Page - Stock Traders Daily

Feb 13, 2025

Feb 12, 2025

Tonix Pharmaceuticals appoints new CTO amid drug development - MSN

Feb 12, 2025

Feb 12, 2025

Tonix Pharmaceuticals reports positive phase 1 results for TNX-1500, advancing to Phase 2 - Proactive Investors USA

Feb 12, 2025

Feb 11, 2025

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights - ADVFN

Feb 11, 2025

Feb 11, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap DownHere's Why - MarketBeat

Feb 11, 2025

Feb 11, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap UpWhat's Next? - MarketBeat

Feb 11, 2025

Feb 10, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 13.2%Should You Buy? - MarketBeat

Feb 10, 2025

Feb 10, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 12.6%Time to Sell? - MarketBeat

Feb 10, 2025

Feb 09, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7%Should You Sell? - MarketBeat

Feb 09, 2025

Feb 08, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.7%What's Next? - MarketBeat

Feb 08, 2025

Feb 08, 2025

Tonix Pharma says it had about $98.8M in cash and cash equivalents as of Dec 31, 2024 - MSN

Feb 08, 2025

Feb 07, 2025

Tonix Pharmaceuticals Rises After Preliminary 2024 Results -February 07, 2025 at 03:39 pm EST - Marketscreener.com

Feb 07, 2025

Feb 07, 2025

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash - GlobeNewswire

Feb 07, 2025

Feb 07, 2025

Tonix stock gains on business update, preliminary earnings report - Seeking Alpha

Feb 07, 2025

Feb 07, 2025

What's Going On With Tonix Pharmaceuticals Shares Friday? - Benzinga

Feb 07, 2025

Feb 07, 2025

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500 - Clinical Trials Arena

Feb 07, 2025

Feb 07, 2025

TNXP Financial Results: Strong Sales Growth & Strategic Cash Position Ahead of Critical FDA Date - StockTitan

Feb 07, 2025

Feb 06, 2025

Tonix Pharma Announces Promising Phase 1 Trial Results - TipRanks

Feb 06, 2025

Feb 06, 2025

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases - GlobeNewswire

Feb 06, 2025

Feb 06, 2025

Breakthrough in Transplant Medicine: Novel Anti-CD40L Antibody Achieves Key Clinical Milestones - StockTitan

Feb 06, 2025

Feb 06, 2025

Tonix Pharmaceuticals announces reverse stock split - MSN

Feb 06, 2025

Feb 05, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Feb 05, 2025

Feb 05, 2025

TNXPTonix Pharmaceuticals Holding Corp. Latest Stock News & Market Updates - StockTitan

Feb 05, 2025

Feb 05, 2025

Tonix Pharmaceuticals to Present at BIO CEO & Investor Conference on February 10, 2025 - Nasdaq

Feb 05, 2025

Feb 05, 2025

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewswire

Feb 05, 2025

Feb 05, 2025

Tonix's FDA Fast-Tracked Fibromyalgia Treatment Takes Center Stage at Major Investor Conference - StockTitan

Feb 05, 2025

Feb 05, 2025

Tonix Pharmaceuticals appoints new CTO amid drug development By Investing.com - Investing.com South Africa

Feb 05, 2025

Feb 04, 2025

Tonix Pharmaceuticals promotes Fogarty to CTO - MSN

Feb 04, 2025

Feb 04, 2025

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer - citybiz

Feb 04, 2025

Feb 04, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.7%Should You Sell? - MarketBeat

Feb 04, 2025

Feb 04, 2025

Tonix Pharma Promotes Fogarty to Chief Technology Officer - TipRanks

Feb 04, 2025

Feb 04, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Craters on Stock Split before FDA Call - TipRanks

Feb 04, 2025

Feb 04, 2025

Tonix's Leadership Shakeup: New CTO to Spearhead $34M Defense Contract & Critical FDA Review - StockTitan

Feb 04, 2025

Feb 04, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% HigherWhat's Next? - MarketBeat

Feb 04, 2025

Feb 04, 2025

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 04, 2025